» Articles » PMID: 34502436

Metabolic Consequences of Gestational Cannabinoid Exposure

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Sep 10
PMID 34502436
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Up to 20% of pregnant women ages 18-24 consume cannabis during pregnancy. Moreover, clinical studies indicate that cannabis consumption during pregnancy leads to fetal growth restriction (FGR), which is associated with an increased risk of obesity, type II diabetes (T2D), and cardiovascular disease in the offspring. This is of great concern considering that the concentration of Δ- tetrahydrocannabinol (Δ9-THC), a major psychoactive component of cannabis, has doubled over the last decade and can readily cross the placenta and enter fetal circulation, with the potential to negatively impact fetal development via the endocannabinoid (eCB) system. Cannabis exposure in utero could also lead to FGR via placental insufficiency. In this review, we aim to examine current pre-clinical and clinical findings on the direct effects of exposure to cannabis and its constituents on fetal development as well as indirect effects, namely placental insufficiency, on postnatal metabolic diseases.

Citing Articles

Prenatal cannabis exposure in the clinic and laboratory: What do we know and where do we need to go?.

Cupo L, Dominguez-Cancino K, Nazif-Munoz J, Chakravarty M Drug Alcohol Depend Rep. 2024; 13:100282.

PMID: 39430603 PMC: 11490891. DOI: 10.1016/j.dadr.2024.100282.


Assessment of the effects of cannabidiol and a CBD-rich hemp extract in .

Camacho J, Welch B, Ferguson M, Sepehr E, Vaught C, Zhao Y Front Toxicol. 2024; 6:1469341.

PMID: 39420966 PMC: 11484448. DOI: 10.3389/ftox.2024.1469341.


Effects of in utero exposure to Δ-9-tetrahydrocannabinol on cardiac extracellular matrix expression and vascular transcriptome in rhesus macaques.

Le H, Shorey-Kendrick L, Hinds M, McCarty O, Lo J, Anderson D Am J Physiol Heart Circ Physiol. 2024; 327(3):H701-H714.

PMID: 39028280 PMC: 11442028. DOI: 10.1152/ajpheart.00181.2024.


Effects of prenatal THC vapor exposure on body weight, glucose metabolism, and feeding behaviors in chow and high-fat diet fed rats.

Hume C, Baglot S, Javorcikova L, Lightfoot S, Scheufen J, Hill M Int J Obes (Lond). 2024; 48(7):981-992.

PMID: 38528095 DOI: 10.1038/s41366-024-01512-8.


Prenatal Exposure to Cannabis: Effects on Childhood Obesity and Cardiometabolic Health.

Moore B Curr Obes Rep. 2024; 13(1):154-166.

PMID: 38172481 PMC: 10933144. DOI: 10.1007/s13679-023-00544-x.


References
1.
Fonseca B, Correia-da-Silva G, Taylor A, Konje J, Bell S, Teixeira N . Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development. Reprod Biol Endocrinol. 2009; 7:121. PMC: 2775033. DOI: 10.1186/1477-7827-7-121. View

2.
Richardson G, Ryan C, Willford J, Day N, Goldschmidt L . Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol. 2002; 24(3):309-20. DOI: 10.1016/s0892-0362(02)00193-9. View

3.
Castel P, Barbier M, Poumerol E, Mandon-Pepin B, Tassistro V, Lepidi H . Prenatal cannabinoid exposure alters the ovarian reserve in adult offspring of rats. Arch Toxicol. 2020; 94(12):4131-4141. DOI: 10.1007/s00204-020-02877-1. View

4.
Rosenstock J, Hollander P, Chevalier S, Iranmanesh A . SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes. Diabetes Care. 2008; 31(11):2169-76. PMC: 2571069. DOI: 10.2337/dc08-0386. View

5.
Oke S, Sohi G, Hardy D . Perinatal protein restriction with postnatal catch-up growth leads to elevated p66Shc and mitochondrial dysfunction in the adult rat liver. Reproduction. 2019; 159(1):27-39. PMC: 6933810. DOI: 10.1530/REP-19-0188. View